Phio Pharmaceuticals Corp. (PHIO) Return on equity 2016–2020
Phio Pharmaceuticals Corp. (PHIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.6%FY2020 · since FY2016: -82.9% → -67.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -67.6% | +87.4 pp |
| FY2019 | -155.0% | -100.8 pp |
| FY2018 | -54.2% | +625.1 pp |
| FY2017 | -679.3% | -596.5 pp |
| FY2016 | -82.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PHIO financial trends
PHIO RevenuePHIO Net incomePHIO Net marginPHIO Gross profitPHIO Gross marginPHIO Operating incomePHIO Operating marginPHIO Operating cash flowPHIO Free cash flowPHIO Capital expendituresPHIO Stock buybacksPHIO Dividends paidPHIO Total assetsPHIO Total liabilitiesPHIO Shareholders’ equityPHIO overview →